BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)_个股概要_股票价格_最新资讯_行情走势_历史数据

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)

盘后1.14-0.05-4.20%19:54 EDT

1.19-0.05-4.03%

社区社区
资讯资讯
资料资料
公告公告

- 最新
- 推荐
公司概况
公司名称
BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.midatechpharma.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
Biodexa Pharmaceuticals PLC，在英格兰和威尔士的法律组建的公开股份有限公司，简称Midatech，是一家专业制药公司，专注于多种治疗产品的开发和商业化，利用其纳米和缓释技术，提升交付在重大疾病与满足医疗需要的药品。这些疾病包括糖尿病，某些癌症如肝，胰，卵巢癌和脑（胶质母细胞瘤），和神经/眼科条件。 Midatech的战略是发展在罕见的癌症和其他适应症的合作伙伴，其产品在公司内部，并通过战略收购互补的产品和技术，以加速其业务增长。
- 04-19
  年度报告
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
  Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
- 03-21
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 03-18
  招股说明书
  Form F-1 - Registration statement for certain foreign private issuers
  Form F-1 - Registration statement for certain foreign private issuers
- 02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-14
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-13
  超过5%披露
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
- 02-13
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 01-09
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2023-12-28
  超过5%披露
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
  Form SC 13G - Statement of acquisition of beneficial ownership by individuals
- 2023-12-16
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2023-12-16
  SEC问询函
  Form CORRESP - Correspondence
  Form CORRESP - Correspondence
- 2023-12-15
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
- 2023-12-08
  [补充]招股说明书
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
  Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
- 2023-12-07
  [修订]招股说明书
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
  Form F-1/A - Registration statement for certain foreign private issuers: [Amend]

分时
5日
日
周
月

最高

1.37

今开

1.37

量比

1.67

最低

1.16

昨收

1.24

换手率

17.47%

热议股票

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

BIODEXA PHARMACEUTICALS PLC SPON ADS EACH REP 5 ORD(BDRX)

公司概况

热议股票